Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CETP | P11597 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | UBE2N | P61088 | 1/20 | 0.42 |
| ▸ | HMGCR | P04035 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5046213 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL12994143 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL1888013 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL5705200 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL1293252 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL15283585 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL6285996 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL9793919 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL15283559 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL15283911 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022023685-A1 | COMPOSITION AND USE OF THIS COMPOSITION FOR FORMING A SOL-GEL COATING ON A METAL SURFACE | ARCANE INDUSTRIES (FR) | 2022-02-03 | — | — | WO | claimed |
| EP-0192130-B1 | CORROSION INHIBITOR COMPOSITION | HENKEL CORPORATION (a Delaware corp.) (US) | 1990-06-27 | — | — | EP | claimed |
| EP-0192130-A2 | Corrosion inhibitor composition | HENKEL CORPORATION (a Delaware corp.) (US) | 1986-08-27 | — | — | EP | claimed |
| US-20240208898-A1 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240208898-A1 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-06-27 | — | — | US | disclosed |
| EP-4313013-A2 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | Dana-Farber Cancer Institute, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| CN-117279629-A | Enamine N-oxide: synthesis and use in hypoxia responsive prodrugs and imaging agents | 达纳－法伯癌症研究所公司 | 2023-12-22 | — | — | CN | disclosed |
| WO-2022204344-A2 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2022-09-29 | — | — | WO | disclosed |
| WO-2022023685-A1 | COMPOSITION AND USE OF THIS COMPOSITION FOR FORMING A SOL-GEL COATING ON A METAL SURFACE | ARCANE INDUSTRIES (FR) | 2022-02-03 | — | — | WO | disclosed |
| EP-3060698-B1 | CHEMICAL INHIBITION OF PITTING CORROSION IN METHANOLIC SOLUTIONS CONTAINING AN ORGANIC HALIDE | BAKER HUGHES HOLDINGS LLC (US) | 2020-11-25 | — | — | EP | disclosed |
| US-10392712-B2 | Chemical inhibition of pitting corrosion in methanolic solutions containing an organic halide | BAKER HUGHES, A GE COMPANY, LLC (US) | 2019-08-27 | — | — | US | disclosed |
| EP-0255098-A1 | Novel 8-(lower alkyl) bicyclo [4.2.0] octane derivatives with valuable therapeutic properties | SYNTEX (U.S.A.) INC. (US) | 1988-02-03 | — | — | EP | disclosed |
| US-4678805-A | Novel 8-(lower alkyl)bicyclo[4.2.0]octane derivatives with valuable therapeutic properties | SYNTEX (U.S.A.) INC. (US) | 1987-07-07 | — | — | US | disclosed |
| EP-0196617-A1 | [4.2.0]bicyclooctane derivatives, process for their preparation and pharmaceutical compositions containing same | SYNTEX (U.S.A.) INC. (US) | 1986-10-08 | — | — | EP | disclosed |
| EP-0192130-A2 | Corrosion inhibitor composition | HENKEL CORPORATION (a Delaware corp.) (US) | 1986-08-27 | — | — | EP | disclosed |
| US-4608388-A | Novel [4,2,0]bicyclooctane derivatives with valuable therapeutic properties | SYNTEX (U.S.A.) INC. (US) | 1986-08-26 | — | — | US | disclosed |
| EP-0139567-A2 | Method and composition for inhibiting corrosion | PUMPTECH N.V. (BE) | 1985-05-02 | — | — | EP | disclosed |
| US-4493775-A | REACTION PRODUCT OF CYCLOHEXYLAMINE, EXCESS FORMALDEHYDE, AND ACETOPHENONE | THE DOW CHEMICAL COMPANY (US) | 1985-01-15 | — | — | US | disclosed |
| US-4444668-A | Well completion fluid compositions | HALLIBURTON COMPANY (US) | 1984-04-24 | — | — | US | disclosed |
| US-3932296-A | AMMONIA DERIVATIVE, QUARTERNARY AMMONIUM COMPOUND | THE DOW CHEMICAL COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240208898-A1 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | ENO1, HIF1A, HIF1AN | GPR84 367/4885SPHK1 312/4885FFAR1 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.